HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 207 filers reported holding HORIZON PHARMA PLC in Q2 2018. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,898,000 | +206.7% | 109,700 | +126.6% | 0.17% | +171.9% |
| Q4 2018 | $945,000 | +0.5% | 48,406 | +0.8% | 0.06% | +60.0% |
| Q3 2018 | $940,000 | +18.2% | 48,000 | 0.0% | 0.04% | +8.1% |
| Q2 2018 | $795,000 | +47.2% | 48,000 | +26.3% | 0.04% | +37.0% |
| Q1 2018 | $540,000 | -49.8% | 38,000 | -48.4% | 0.03% | -48.1% |
| Q4 2017 | $1,076,000 | +15.2% | 73,687 | 0.0% | 0.05% | +13.0% |
| Q3 2017 | $934,000 | +67.4% | 73,687 | +56.5% | 0.05% | +70.4% |
| Q2 2017 | $558,000 | -9.0% | 47,087 | +13.5% | 0.03% | -27.0% |
| Q1 2017 | $613,000 | -56.4% | 41,487 | -52.3% | 0.04% | -51.9% |
| Q4 2016 | $1,407,000 | +3.5% | 86,960 | +16.0% | 0.08% | +16.7% |
| Q3 2016 | $1,360,000 | +144.6% | 74,960 | +121.8% | 0.07% | +78.4% |
| Q2 2016 | $556,000 | +8.2% | 33,800 | +9.0% | 0.04% | +15.6% |
| Q1 2016 | $514,000 | -74.4% | 31,000 | -66.5% | 0.03% | -73.1% |
| Q4 2015 | $2,007,000 | +913.6% | 92,560 | +825.6% | 0.12% | +891.7% |
| Q3 2015 | $198,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JABODON PT CO | 187,808 | $4,519,000 | 3.52% |
| KNOTT DAVID M | 50,046 | $1,204,000 | 0.51% |
| CASTLEARK MANAGEMENT LLC | 362,980 | $8,733,000 | 0.34% |
| EAGLE ASSET MANAGEMENT INC | 2,692,100 | $64,771,000 | 0.33% |
| USA FINANCIAL FORMULAS | 15,202 | $402,000 | 0.20% |
| Qtron Investments LLC | 12,274 | $295,000 | 0.18% |
| C WorldWide Group Holding A/S | 491,544 | $11,827,000 | 0.15% |
| Gotham Asset Management, LLC | 207,158 | $4,984,000 | 0.08% |
| Russell Investments Group, Ltd. | 608,977 | $14,652,000 | 0.03% |
| FNY Investment Advisers, LLC | 3,350 | $80,000 | 0.02% |